John Adcock
- Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cellsBy Laura Price, Frederic Perros, Dongmin Shao, Jie Zhu, David Montani, Peter Dorfmuller, John Wharton, Marc Humbert, Ian Adcock and John WortLaura Price1Department of Pulmonary Hypertension, Royal Brompton Hospital, London, United KingdomFrederic Perros2Service de Pneumologie et Réanimation Respiratoire, Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Antoine Béclère, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris 157, Rue de la Porte de Tr, Clamart, Paris, FranceDongmin Shao1Department of Pulmonary Hypertension, Royal Brompton Hospital, London, United KingdomJie Zhu3Department of Histology, Royal Brompton Hospital, London, United KingdomDavid Montani2Service de Pneumologie et Réanimation Respiratoire, Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Antoine Béclère, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris 157, Rue de la Porte de Tr, Clamart, Paris, FrancePeter Dorfmuller2Service de Pneumologie et Réanimation Respiratoire, Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Antoine Béclère, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris 157, Rue de la Porte de Tr, Clamart, Paris, FranceJohn Wharton4Section on Experimental Medicine and Toxicology, Imperial College London, Hammersmith Hospital, London, United KingdomMarc Humbert2Service de Pneumologie et Réanimation Respiratoire, Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Antoine Béclère, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris 157, Rue de la Porte de Tr, Clamart, Paris, FranceIan Adcock5Cell & Molecular Biology Airways Disease Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United KingdomJohn Wort1Department of Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom
- Investigating the role of prostaglandin D2 in airway sensory nerve firing: Relevance to diseaseBy Sarah Maher, Mark Birrell, John Adcock, Michael Wortley, Sara Bonvini, Megan Grace and Maria BelvisiSarah Maher1Respiratory Pharmacology, Imperial College London, London, United KingdomMark Birrell1Respiratory Pharmacology, Imperial College London, London, United KingdomJohn Adcock1Respiratory Pharmacology, Imperial College London, London, United KingdomMichael Wortley1Respiratory Pharmacology, Imperial College London, London, United KingdomSara Bonvini1Respiratory Pharmacology, Imperial College London, London, United KingdomMegan Grace1Respiratory Pharmacology, Imperial College London, London, United KingdomMaria Belvisi1Respiratory Pharmacology, Imperial College London, London, United Kingdom
- Nuclear factor-kappa B inhibition exerts anti-remodelling effects in pulmonary arterial smooth muscle cellsBy Laura Price, Dongmin Shao, Chao Meng, Frederic Perros, David Montani, Peter Dorfmuller, Marc Humbert, Ian Adcock and John WortLaura Price1Pulmonary Hypertension Service, Royal Brompton Hospital, London, United Kingdom2National Heart & Lung Institute, Imperial College London, London, United KingdomDongmin Shao2National Heart & Lung Institute, Imperial College London, London, United KingdomChao Meng2National Heart & Lung Institute, Imperial College London, London, United KingdomFrederic Perros3Service de Pneumologie et Réanimation Respiratoire, Hôpital Bicêtre, 78 rue du Général Leclerc, Le Kremlin-Bicêtre, Paris, France4INSERM U999, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Université Paris-Sud - LabEx LERMIT - DHU Thorax Innovation (TORINO), Centre Chirurgical Marie Lannelongue, Paris, FranceDavid Montani3Service de Pneumologie et Réanimation Respiratoire, Hôpital Bicêtre, 78 rue du Général Leclerc, Le Kremlin-Bicêtre, Paris, France4INSERM U999, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Université Paris-Sud - LabEx LERMIT - DHU Thorax Innovation (TORINO), Centre Chirurgical Marie Lannelongue, Paris, FrancePeter Dorfmuller3Service de Pneumologie et Réanimation Respiratoire, Hôpital Bicêtre, 78 rue du Général Leclerc, Le Kremlin-Bicêtre, Paris, France4INSERM U999, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Université Paris-Sud - LabEx LERMIT - DHU Thorax Innovation (TORINO), Centre Chirurgical Marie Lannelongue, Paris, FranceMarc Humbert3Service de Pneumologie et Réanimation Respiratoire, Hôpital Bicêtre, 78 rue du Général Leclerc, Le Kremlin-Bicêtre, Paris, France4INSERM U999, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Université Paris-Sud - LabEx LERMIT - DHU Thorax Innovation (TORINO), Centre Chirurgical Marie Lannelongue, Paris, FranceIan Adcock2National Heart & Lung Institute, Imperial College London, London, United KingdomJohn Wort1Pulmonary Hypertension Service, Royal Brompton Hospital, London, United Kingdom2National Heart & Lung Institute, Imperial College London, London, United Kingdom
- Cromoglycate: Breathing life into an old asthma drugBy Sarah Maher, Mark Birrell, Katie Baker, Kristof Raemdonck, Sara Bonvini, John Adcock, Michael Wortley, Eric Dubuis, Fisnik Shala, Victoria Jones, Peter Barnes, Rajamannar Thennati, Biswajit Samanta, Dipali Desai, Anil Kumbhani and Maria BelvisiSarah Maher1Airway Disease, NHLI, Imperial College, London, United KingdomMark Birrell1Airway Disease, NHLI, Imperial College, London, United KingdomKatie Baker1Airway Disease, NHLI, Imperial College, London, United KingdomKristof Raemdonck1Airway Disease, NHLI, Imperial College, London, United KingdomSara Bonvini1Airway Disease, NHLI, Imperial College, London, United KingdomJohn Adcock1Airway Disease, NHLI, Imperial College, London, United KingdomMichael Wortley1Airway Disease, NHLI, Imperial College, London, United KingdomEric Dubuis1Airway Disease, NHLI, Imperial College, London, United KingdomFisnik Shala1Airway Disease, NHLI, Imperial College, London, United KingdomVictoria Jones1Airway Disease, NHLI, Imperial College, London, United KingdomPeter Barnes1Airway Disease, NHLI, Imperial College, London, United KingdomRajamannar Thennati2Research & Development, Sun Pharma Advanced Research Company Ltd, Tandalja, Vadodara, Gujarat IndiaBiswajit Samanta2Research & Development, Sun Pharma Advanced Research Company Ltd, Tandalja, Vadodara, Gujarat IndiaDipali Desai2Research & Development, Sun Pharma Advanced Research Company Ltd, Tandalja, Vadodara, Gujarat IndiaAnil Kumbhani2Research & Development, Sun Pharma Advanced Research Company Ltd, Tandalja, Vadodara, Gujarat IndiaMaria Belvisi1Airway Disease, NHLI, Imperial College, London, United Kingdom
- TRPV4 and activation of airway sensory nerves: The role of ATPBy Sara Bonvini, Mark Birrell, Megan Grace, Sarah Maher, John Adcock, Michael Wortley, Eric Dubuis, Yee-Man Ching, Anthony Ford, Fisnik Shala, Montserrat Miralpiex, Gema Tarrason, Jaclyn Smith and Maria BelvisiSara Bonvini1NHLI, Imperial College, London, United KingdomMark Birrell1NHLI, Imperial College, London, United KingdomMegan Grace2School of Medical Sciences and Health Innovations Research Institute, RMIT University, Bundoora, AustraliaSarah Maher1NHLI, Imperial College, London, United KingdomJohn Adcock1NHLI, Imperial College, London, United KingdomMichael Wortley1NHLI, Imperial College, London, United KingdomEric Dubuis1NHLI, Imperial College, London, United KingdomYee-Man Ching1NHLI, Imperial College, London, United KingdomAnthony Ford4Afferent Pharmaceuticals Inc, Afferent Pharmaceuticals, San Mateo, CA United StatesFisnik Shala1NHLI, Imperial College, London, United KingdomMontserrat Miralpiex5Respiratory Therapeutic Area - Discovery, R&D Centre, Barcelona, SpainGema Tarrason5Respiratory Therapeutic Area - Discovery, R&D Centre, Barcelona, SpainJaclyn Smith3Respiratory and Allergy Centre, University of Manchester, Manchester, United KingdomMaria Belvisi1NHLI, Imperial College, London, United Kingdom
- Organic components of diesel exhaust particles (DEP) activate airway sensory nerves via transient receptor potential ankrin-1 (TRPA1) ion channelsBy Ryan Robinson, Michael Wortley, Eric Dubuis, Shu Chen, Sheng Hu, Sara Bonvini, Sarah Maher, John Adcock, Ian Mudway, Alexandra Porter, Terry Tetley, Mark Birrell and Maria BelvisiRyan Robinson1National Heart and Lung Institute, Imperial College London, London, United KingdomMichael Wortley1National Heart and Lung Institute, Imperial College London, London, United KingdomEric Dubuis1National Heart and Lung Institute, Imperial College London, London, United KingdomShu Chen2Department of Materials, Imperial College London, London, United KingdomSheng Hu3Department of Chemistry, Imperial College London, London, United KingdomSara Bonvini1National Heart and Lung Institute, Imperial College London, London, United KingdomSarah Maher1National Heart and Lung Institute, Imperial College London, London, United KingdomJohn Adcock1National Heart and Lung Institute, Imperial College London, London, United KingdomIan Mudway4Environmental Research Group, Kings College London, London, United KingdomAlexandra Porter2Department of Materials, Imperial College London, London, United KingdomTerry Tetley1National Heart and Lung Institute, Imperial College London, London, United KingdomMark Birrell1National Heart and Lung Institute, Imperial College London, London, United KingdomMaria Belvisi1National Heart and Lung Institute, Imperial College London, London, United Kingdom
- Anti-tussive effects of FAAH inhibition: The role of endocannabinoids and downstream signalling pathways in the inhibition of vagal sensory nerve activationBy Michael Wortley, John Adcock, Eric Dubuis, Sarah Maher, Sara Bonvini, Mark Birrell and Maria BelvisiMichael WortleyNHLI, Imperial College, London, United KingdomJohn AdcockNHLI, Imperial College, London, United KingdomEric DubuisNHLI, Imperial College, London, United KingdomSarah MaherNHLI, Imperial College, London, United KingdomSara BonviniNHLI, Imperial College, London, United KingdomMark BirrellNHLI, Imperial College, London, United KingdomMaria BelvisiNHLI, Imperial College, London, United Kingdom
- Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM)By Sara Bonvini, Mark Birrell, Eric Dubuis, John Adcock, Victoria Jones, Pauline Flajolet, Sepideh Poushpas, Mengqi Wang, S. Mark Duffy, Peter Bradding, Kevin Langley and Maria BelvisiSara Bonvini1NHLI, Imperial College, London, United KingdomMark Birrell1NHLI, Imperial College, London, United KingdomEric Dubuis1NHLI, Imperial College, London, United KingdomJohn Adcock1NHLI, Imperial College, London, United KingdomVictoria Jones1NHLI, Imperial College, London, United KingdomPauline Flajolet1NHLI, Imperial College, London, United KingdomSepideh Poushpas1NHLI, Imperial College, London, United KingdomMengqi Wang1NHLI, Imperial College, London, United KingdomS. Mark Duffy2Respiratory Medicine, Glenfield Hospital, Sheffield, United KingdomPeter Bradding2Respiratory Medicine, Glenfield Hospital, Sheffield, United KingdomKevin Langley3Phase Focus, Electric Works, Sheffield, United KingdomMaria Belvisi2Respiratory Medicine, Glenfield Hospital, Sheffield, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.